National

Trump sues TV network over Kamala Harris interview

Nov 01, 2024

Washington [US], November 1: Presidential candidate Donald Trump is suing broadcaster CBS over an interview of his rival Kamala Harris aired on its 60 Minutes news program, alleging the segment was misleading, according to a court filing.
The complaint, filed in federal court, alleges the network aired two different responses from Harris responding to a question about the war between Israel and Hamas in Gaza.
The version that aired during the 60 Minutes program on October 6 did not include what the lawsuit calls a "word salad" response from Harris about the Biden administration's influence on Israel's conduct of the war.
"Former President Trump's repeated claims against 60 Minutes are false," a CBS News spokesperson said.
"The lawsuit Trump has brought today against CBS is completely without merit and we will vigorously defend against it."
Trump and Harris face each other in what polls show to be a tight race ahead of Tuesday's US presidential election.
The suit demanded a jury trial and about $US10 billion ($A15 billion) in damages, the filing showed. It alleges violations of a Texas law barring deceptive acts in the conduct of business.
Trump has repeatedly assailed the network on the campaign trail over the episode and has threatened to revoke CBS's broadcasting licence if elected.
CBS has said Trump backed out of his own planned interview with 60 Minutes.
Source: Fijian Broadcasting Corporation

More news

Remedium Lifecare Rights Issue Gains Momentum: 26% Subscribed Within First Two Days

Mumbai (Maharashtra) [India], May 5: The Rights Issue of Remedium Lifecare Ltd marks a significant milestone in the company's growth journey. Remedium Lifecare is a rapidly growing company specializing in the trading and distribution of raw materials as part of supply chain management for the pharmaceutical industry. The issue has been receiving tremendous response from investors and shareholders, with a subscription of 26.03% by the end of Day 2.

May 05, 2025